Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,237 | 2,796 | 350 | 630 | 6,870 |
| Other current assets | 0 | 0 | 7,010 | 6,680 | 70 |
| TOTAL | $3,237 | $2,847 | $7,360 | $7,310 | $6,940 |
| Non-Current Assets | |||||
| PPE Net | 30 | 34 | 40 | 30 | 10 |
| Intangibles | 6,939 | 7,610 | 0 | 0 | 0 |
| Other Non-Current Assets | 27 | 27 | 8,300 | 8,974 | 10,340 |
| TOTAL | $6,997 | $7,671 | $8,340 | $9,004 | $10,350 |
| Total Assets | $10,234 | $10,518 | $15,710 | $16,320 | $17,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 220 | 267 | 450 | 60 | 90 |
| Accrued Expenses | 192 | 146 | 420 | 370 | 1,960 |
| Other current liabilities | 345 | N/A | 0 | 0 | 0 |
| TOTAL | $827 | $462 | $880 | $800 | $2,600 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 320 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $320 |
| Total Liabilities | $827 | $462 | $880 | $800 | $2,930 |
| Shareholders' Equity | |||||
| Common Shares | 67 | 53 | 40 | 40 | 20 |
| Retained earnings | -67,798 | -55,476 | -45,200 | -35,200 | -26,330 |
| Other shareholders' equity | 0 | 0 | 10 | 0 | 10 |
| TOTAL | $9,407 | $10,056 | $14,830 | $15,520 | $14,380 |
| Total Liabilities And Equity | $10,234 | $10,518 | $15,710 | $16,320 | $17,310 |